SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-004593
Filing Date
2022-02-03
Accepted
2022-02-03 16:19:40
Documents
2
Period of Report
2022-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6228
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3864
  Complete submission text file 0000899243-22-004593.txt   11606
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZIOPHARM ONCOLOGY, INC. ONE FIRST AVENUE, PARRIS BUILDING #34 BOSTON MA 02129
Business Address
Shukla Sath (Reporting) CIK: 0001782817 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38266 | Film No.: 22588559